Active Ingredient History

  • Now
Ofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic acid, primary mechanism of action is inhibition of bacterial DNA gyrase. It is an orally administered broad spectrum antibacterial drug active against most Gram-negative bacteria, many Gram-positive bacteria and some anaerobes. Clinical trials to date have demonstrated the efficacy of ofloxacin in the treatment of lower respiratory tract infections, urinary tract infections, and sexually transmitted diseases. Adverse effects to ofloxacin are usually mild and include gastrointestinal, central nervous system, and hypersensitivity reactions. Also available in solution for treatment of otic and ophthalmic bacterial infections.   NCATS

  • Mol. Mass: 361.3675
  • ALogP: 1.54
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$1.8050 - $23.2740
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

8-fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6h-1-oxa-3a-aza-phenalene-5-carboxylic acid | dl-8280 | exocin | floxin | floxin otic | gailuoxian | hoe-280 | ocuflox | ofloxacin | (-)-ofloxacin | ofloxacine | ofloxacin hcl | ofloxacin hydrochloride | ofloxacino | ofloxacin s-(-)-form | ofloxacinum | oflx | oxaldin | prifloxcin | prifloxin | (s)-ofloxacin | tarivid | tarivid 400 | tarivid i.v. | visiren


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue